- |||||||||| NN1213 / Novo Nordisk
Enrollment change, Trial termination, Trial primary completion date: Studies of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (clinicaltrials.gov) - Oct 6, 2015 P1, N=28, Terminated, N=40 --> 28 | Active, not recruiting --> Terminated | Trial primary completion date: Dec 2012 --> Sep 2014; Inability to recruit the patients due to the short supply and changed local hospital protocol
- |||||||||| Trial completion, Trial primary completion date, HEOR: ALTOS: Evaluating Health Outcomes and QOL After ALI Among Participants of the ALTA, OMEGA, EDEN, and SAILS ARDS Network Trials (clinicaltrials.gov) - Sep 1, 2015
P=N/A, N=922, Completed, Recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Apr 2015 --> Oct 2014
- |||||||||| Trial suspension, Trial primary completion date: NHFOV Versus NCPAP to Prevent Exubation Failure (clinicaltrials.gov) - Aug 13, 2015
P=N/A, N=20, Suspended, Trial primary completion date: Jul 2015 --> Jul 2016 Not yet recruiting --> Suspended | Trial primary completion date: Dec 2013 --> Dec 2015
- |||||||||| ketamine / Generic mfg.
Trial completion: Pharmacokinetic Alterations During ECMO (clinicaltrials.gov) - Aug 11, 2015 P=N/A, N=20, Completed, Recruiting --> Completed | N=20 --> 10 | Trial primary completion date: Dec 2014 --> Aug 2014 Active, not recruiting --> Completed
- |||||||||| Enrollment change, Trial termination: Different Lipid Emulsions in Acute Lung Injury Patients (clinicaltrials.gov) - Jul 13, 2015
P4, N=1, Terminated, Enrolling by invitation --> Completed | Trial primary completion date: Dec 2012 --> Dec 2013 N=30 --> 1 | Recruiting --> Terminated; Low recruitment
- |||||||||| Trial completion, Enrollment change, Trial primary completion date: Comparing Bubble and Ventilator Nasal CPAP in Preterm Infants (clinicaltrials.gov) - Jun 30, 2015
P=N/A, N=18, Completed, Not yet recruiting --> Recruiting Recruiting --> Completed | N=40 --> 18 | Trial primary completion date: Jun 2014 --> Oct 2014
|